MX003

Guadalajara

0 studies enrolling now · 2 studies all time

What they study most

Dravet Syndrome

Studies at this site

• Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome — Stopped early
• Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome — Withdrawn before enrolling